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Coronavirus disease 2019 (COVID-19) requires admission to intensive care (ICU) for the
management of acute respiratory distress syndrome in about 5% of cases. Although our
understanding of COVID-19 is still incomplete, a growing body of evidence is indicating
potential direct deleterious effects on the central and peripheral nervous systems.
Indeed, complex and long-lasting physical, cognitive, and functional impairments have
often been observed after COVID-19. Early (defined as during and immediately after
ICU discharge) rehabilitative interventions are fundamental for reducing the neurological
burden of a disease that already heavily affects lung function with pulmonary fibrosis as
a possible long-term consequence. In addition, ameliorating neuromuscular weakness
with early rehabilitation would improve the efficiency of respiratory function as respiratory
muscle atrophy worsens lung capacity. This review briefly summarizes the polymorphic
burden of COVID-19 and addresses possible early interventions that could minimize
the neurological and systemic impact. In fact, the benefits of early multidisciplinary
rehabilitation after an ICU stay have been shown to be advantageous in several
clinical conditions making an early rehabilitative approach generalizable and desirable
to physicians from a wide range of different specialties.
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INTRODUCTION
Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), is a major burden on Intensive Care Units (ICU) because of the high
number of patients eventually requiring respiratory support measures. Although most COVID-19
patients are asymptomatic or experience mild illness, ∼15% become severely ill, requiring oxygen
therapy. A further 5% are admitted to an ICU, where they require invasive ventilation for acute
respiratory distress syndrome (ARDS) (1).
Regardless of the underlying pathology, prolonged ICU stay frequently involves sedation and
immobilization (often in a prone position). This is associated with musculoskeletal, pulmonary,
cardiovascular, immunological, endocrine, and metabolic complications (2). Musculoskeletal
consequences are especially relevant and include muscle atrophy, decreased strength, reduced
protein synthesis, joint contractures, bone density decrease, and pressure ulcers. Nearly 50% of ICU
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patients show critical illness-associated neuromuscular
abnormalities (3). If ventilatory support is maintained for
longer than 14 days, a tracheotomy is recommended (4). As a
result, a high proportion of COVID-19 patients undergo this
procedure in their extended ICU stay.
The complexity of ICU patient management is compounded
if the underlying disease touches the central and/or peripheral
nervous system (CNS, PNS). In the case of COVID-19, emerging
preliminary evidence points toward significant neurological
involvement (5–8). Actually, possible nervous system infection
could occur by direct entry of the virus via the cribriform plate
(8) or, through systemic circulatory dissemination following
infection of the lungs. COVID-19 patients admitted to ICU
should therefore be considered as especially critical given
the potential nervous system involvement. A higher risk of
developing transient or persistent neuromuscular and/or
neurological sequelae/deficits is consequently conceivable
(Figure 1).
In this respect, early (defined as during and immediately
after ICU discharge) rehabilitative interventions are fundamental
in reducing possible added neurological burden to a disease
that already greatly affects lung function, potentially causing
pulmonary fibrosis in the long-term. In addition, managing
neuromuscular weakness would improve the efficiency of
respiratory function, as respiratory muscle atrophy worsens
lung capacity.
Here, we first briefly summarize the current knowledge
on the repercussions of COVID-19, mainly focusing on the
neurological manifestations and complications. We compiled the
available literature by performing computer searches of English-
language databases (Medline, PubMed Central, Google Scholar)
combining the relevant keywords (“COVID-19,” “Coronavirus,”
“early rehabilitation,” “neurological complications”) up to 1st
May 2020. Then, we address early rehabilitative interventions
that could minimize the neurological impact of COVID-19.
Many lessons can be learnt from the cumulative experience
of early rehabilitation strategies applied in the acute stage on
severely and critically ill patients. However, it is pertinent to point
out that this knowledge continues to evolve as new data is being
shared regularly, and new recommendations may be provided as
more evidence emerges.
WHY COVID-19 IMPAIRS RECOVERY
Several features, comorbidities, and complications of COVID-
19 are associated with adverse effects on multiples organs and
systems other than the respiratory system, which may then lead
to high levels of physical, cognitive, and functional impairment.
Rehabilitation treatment plans for patients with COVID-19
or recovering from it, ought to take into consideration these
implications to restore impaired functions and prevent long-
term consequences.
CNS Involvement
Adverse cerebrovascular events have been reported in COVID-
19 patients who developed severe respiratory complications (1).
In one study, hypoxic/ischemic encephalopathy was reported
in ∼20% of 113 patients who all died from COVID-19
(9). Additionally, a recent investigation from China found
that among 214 COVID-19 patients, approximately one
third experienced neurological manifestations, including acute
cerebrovascular disease, and impaired consciousness (10).
Hemorrhagic necrotizing encephalopathy and medio-temporal
epileptic encephalitis have also been reported (11, 12). In a
French consecutive cases series of 58 severe acute-COVID-19
patients, encephalopathy with prominent agitation, confusion,
and corticospinal tract signs were observed in almost two thirds
of cases. Eight out of 13 patients who received a brain MRI
in this series showed an enhancement of the leptomeningeal
spaces. Furthermore, in the 11 patients who underwent perfusion
imaging, all showed bilateral frontotemporal hypoperfusion (13).
Importantly in this cohort, enduring dysexecutive symptoms
accompanied recovery, identifying a target for late rehabilitation
effort and follow-up treatment.
The link between COVID-19 and cerebrovascular disease
remains controversial but many findings suggest that ischemic
stroke occurs in the context of a systemic, highly pro-
thrombotic state. An increase in the number of large vessel
occlusion malignant strokes has been independently reported
(14–16), combined with a higher number of life-threatening
thrombotic complications (17). Post-mortem observations have
demonstrated multi-organ endothelitis with significant micro-
vascular impairment (18).
Although based on a limited amount of data, some
evidence suggests that coronaviruses may cause damage to
the dopaminergic system. A selective affinity of coronaviruses
for the basal ganglia and limbic system has been reported in
rodent models of encephalitis induced by intranasal inoculation
(19). Specifically, intraneuronal transport was posited as the
spreading mechanism of the viruses (20). In humans, high anti-
coronavirus antibody titers were observed in the cerebrospinal
fluid of Parkinson’s disease patients (21). Furthermore, using
electron-microscopy the virus was detected in frontal-lobe
tissue (22). Prolonged confusion after sedation withdrawal and
impaired consciousness have also been described in COVID-
19 patients (23). This is not surprising given that functional
disturbance of the forebrain systems (frontal/prefrontal, cortical-
striato-pallidal, and thalamocortical loop systems) are known
to be associated with cognitive-motor dissociation in severe
brain injuries. Cognitive-motor dissociation is characterized
by blocked motor preparation and action (24). Of note, the
possibility that dopaminergic systems may become deregulated
suggests that in some COVID-19 patients, altered consciousness
may reflect a functional akinetic mutism (25); in such
instances a more marked alteration of resting metabolism
could be diagnostic or the direct evaluation of altered
dopaminergic transmission (26). In summary, COVID-19 can
induce neurological sequelae by attacking the CNS in a
multifaceted way. This includes vascular, inflammatory, and/or
direct neuronal injury. Furthermore, this neurological intrusion
may be clinically silent because of sedation and avoidance
of certain diagnostic procedures to reduce the risk of cross
infection including lumbar puncture, brain imaging, and
electromyography/nerve conduction velocity.
Frontiers in Neurology | www.frontiersin.org 2 August 2020 | Volume 11 | Article 880
Pincherle et al. Early Rehabilitation and COVID-19
PNS Involvement and Critical Care Illness
Several cases of post-COVID-19 acute polyneuropathy have
been reported (7, 27–32) with electro-clinical characteristics of
Guillain Barré syndrome. These include acute inflammatory
demyelinating and motor-sensory axonal subtypes. In the largest
case series to date, Toscano et al. (32) demonstrated that
of five Italian patients, an axonal variant was observed in
three of them and a demyelinating form in two. Furthermore,
two cases of Miller-Fisher variant, a Guillain Barré subtype
with cranial nerve involvement, have also been described (33).
Mao et al. (10) first proposed that anosmia and ageusia
in COVID-19 patients reflected involvement at the cranial
nerve level. In line with this theory, a large case-controlled
study of COVID-19 patients presenting with smell and/or
taste disorders, found that < 15% reported concomitant nasal
obstruction indicating a primary dysfunction of the olfactory
tract (34).
Data are still lacking to prove a specific association between
critical illness–related myopathy or neuropathy (CRIMYNE) and
COVID-19. However, data from the severe acute respiratory
syndrome (SARS) outbreak in 2003 indicated that myopathies
with severe muscle wasting and myalgias, were very frequently
associated with coronavirus infections (35). As previously
stated, nearly 50% of ICU patients present critical illness-
associated neuromuscular abnormalities (3). It is therefore
arguable that COVID-19 patients are especially at risk of
PNS damage.
Respiratory Impairment and Tracheotomy
COVID-19 causes varying degrees of lung complication. These
range from mild to severe pneumonia, ARDS, and sepsis. In
mild or uncomplicated illness, patients present with symptoms
of upper respiratory tract viral infection. These symptoms
include mild fever, a dry cough, sore throat, nasal congestion,
malaise, headache, and muscle pain. In severe pneumonia,
fever is associated with serious dyspnea, respiratory distress,
tachypnea (> 30 breaths/min), and hypoxia (SpO2 < 90% on
room air) (36). Chest imaging results may be normal in early
or mild disease, however, in patients requiring hospitalization,
69% have abnormal chest X-Rays at admission (37). The most
frequent findings on X-Ray and CT scans are airspace opacities
including ground-glass opacity or consolidation. Distribution is
most often bilateral, peripheral, and lower zone predominant
(37). In some patients, major alveolar damage results in
hypoxemic acute respiratory failure (ARF), requiring mechanical
ventilation and ICU admission. Moreover, respiratory viral
infections predispose to co-infections resulting in increased
disease severity and mortality. Zhou et al. (38) showed that 50%
of patients who died from COVID-19 had secondary bacterial
infections. Additionally, Chen et al. (9) recorded bacterial
and fungal co-infections in COVID-19 patients. Although 71%
of patients admitted with COVID-19 receive antibiotics, no
information is available on the antimicrobial sensitivities of the
organisms identified or on the type and duration of antimicrobial
treatment (39).
Chronic obstructive pulmonary disease (COPD) is a risk
factor for severe COVID-19. Many patients with COPD have
underlying chronic bacterial infections prior to the SARS-CoV-
2 infection; however, this important information is not being
reported. Given the neuro-invasive potential of SARS-CoV-
2 and the peculiar severity of respiratory failure observed in
COVID-19 patients, researchers have suggested involvement
of the CNS respiratory centers (40). However, to date, there
are no data proving SARS-CoV-2 invasion of brainstem
dorsal root neurons; furthermore, recovery is typically longer
and more difficult in patients having neuroinflammation or
neurodegeneration in these areas than in COVID-19 disease
(41). While the majority of patients recover from pneumonia
without any lasting lung damage, the lasting effects of COVID-
19-associated pneumonia may be drastic. Following recovery
from acute COVID-19, lung injury may lead to shortness
of breath that takes months to get better. Indeed, COVID-
19 patients who recover from ARDS may have lasting
pulmonary scarring/fibrosis.
In a typical non-COVID-19 ICU patient cohort, early
tracheotomy is often performed for critically-ill ventilated
patients based on several arguments, including decreasing the
duration of mechanical ventilation and ICU stay. However,
the ensuing reduction in mortality rate described in several
studies, remains a matter of controversy (42–45). It is widely
accepted that tracheostomy presents various drawbacks with
delayed effects. These include swallowing disorders, mucous
plugs, and granulations. Cuff inflation, which causes irritation or
damage to the tracheal mucosa, is related to these consequences.
In addition, the lack of air-flow induces deafferentation of
the oropharyngeal region, which perturbs the swallowing
process (46).
Tracheostomy patients requiring repeated aspirations might
need continual monitoring and significant support, which incurs
additional costs. Rapid and safe weaning of tracheostomy
patients is therefore an important goal. Several recent studies
have confirmed that a multidisciplinary approach significantly
reduces weaning time in acute care (47).
Cognitive Impairment
Neurocognitive impairments in COVID-19 patients have not
yet been widely reported. Nonetheless, the tendency of SARS-
CoV-2 to invade and disseminate into the CNS through a
synapse-connected route, similarly to other coronaviruses, may
lead to severe neurological consequences (48, 49). A recent
systematic review suggested that a substantial proportion of
patients with severe COVID-19 were highly likely to experience
a impaired mental status (5). Furthermore, recent findings
of a retrospective study of 214 COVID-19 patients described
various neurological manifestations. Among the severe cases,
impaired consciousness was observed in 14.8% (10). Neuro-
radiological investigation of the first meningitis/encephalitis
case associated with SARS-CoV-2 demonstrated inflammation
in brain structures supporting memory functions, namely
the medial temporal lobe including the hippocampus (12).
Early case reports from Italy highlighted the importance
of recognizing the development of encephalopathy both
as a risk during hospital stay and, as a symptom of
COVID-19 (50). In addition, older age and preexisting
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cognitive conditions were highlighted as enhancing the risk
of developing encephalopathy during acute infection and
critical illness. Indeed, neurological dysfunction, including
delirium and cognitive impairment, is extremely common
following critical illness and its pharmacological management
(51, 52).
The majority of the literature concludes that several
mechanisms such as hypoxemia, glucose dysregulation, and the
effects of sedation contribute to development of neurological
dysfunction. Studies regarding cognitive outcomes following
critical illness report damage over a range of domains including
attention, memory, processing speed, and executive function
(52–54). A large cohort study of 821 patients in medical and
surgical ICUs estimated a high risk of long-term cognitive
impairment following critical illness (55). They reported a
significant positive correlation between longer duration of
delirium with worse global cognition and executive function
scores at 3 and 12 months. Moreover, deficits in executive
abilities are prominent in patients suffering from conditions
such as ARDS, which include symptoms resulting from
hypoxemia. This is coherent with the evidence suggesting
that structures within the frontal circuits are sensitive to
hypoxia (56).
Literature specifically regarding the long-term outcomes in
ARDS survivors reported that 1 year after discharge, the majority
experienced neuropsychological disabilities including impaired
memory, attention, concentration, and mental-processing speed
and a global intellectual decline. Prevalence ranged from 25 (57)
to 78% depending on the severity of the ARDS (51). A prospective
multicenter study in 174 ARDS patients found that at 12 months,
25% of survivors had cognitive impairment in their executive
functions, language, immediate, and delayed memory, verbal
reasoning and concept formation, and attention and working
memory. However, 36% showed significant improvement at
6 months (58). In another study, 82 ARDS survivors self-
reported a high prevalence of depressive symptoms and a
low prevalence of memory deficits 6–48 months after ICU
discharge (59).
As new data on the novel coronavirus SARS-CoV2 continue
to reveal its involvement in the CNS, primary deficits in
executive functions, attention, and memory may be expected
and should be addressed immediately in the acute phase.
In this respect, early (unpublished) clinical data from post-
acute COVID-19 infected patients in our Swiss hospital
are consistent with the expectations. They exposed that
executive deficits ranged from light to severe, that attention
disturbances were observed in all patients, and more than
two-thirds presented memory alteration. Furthermore, from
our clinical neurological examination of acute COVID-19
patients in the ICU, severe forms of akinesia were frequently
encountered. This may lead to clinical underestimation of
conscious awareness in the acute phase, a condition described
as cognitive-motor dissociation (60). Indeed, in cases of
severely impaired motor output, a patient’s cognitive capacity
to interact may be hampered and misdiagnosed as reflecting
forms of severe altered consciousness carrying unfavorable
prognosis (61, 62).
FIGURE 1 | Covid-19 direct and indirect effects.
FIGURE 2 | Covid-19 effects of early rehabilitation.
REHABILITATION STRATEGIES TO
ENHANCE RECOVERY AFTER COVID-19
Rehabilitation is a complex intervention that focuses on
reducing disability, decreasing dependency, and increasing
the quality of life. Early rehabilitative interventions following
COVID-19 could be similar to those of patients with severe
brain injuries or critical illnesses also requiring a prolonged
ICU stay. In this respect, they should target recovery of
the respiratory system and cardiovascular reconditioning
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but also recovery of mobility, functioning, and cognition
(Figure 2). Rehabilitative intervention programs should be
implemented according to the framework of the International
Classification of Functioning, Disability, and Health (63, 64),
which integrates an individualized treatment plan addressing
personal functioning, disease and disability. This promotes and
optimizes functional independence thus maximizing a return to
participation in society.
Early Mobilization
Muscle deconditioning occurs very early with bed rest, involving
a decline in muscle mass, strength, and aerobic efficiency. ICU-
acquired weakness is found in in ∼25% of patients (65). This
worsens acute morbidity and increases the mortality risk at 1 year
(66). Mechanically ventilated patients warrant close attention
because of the increased risk of developing ICU-acquired
weakness (67). In this respect, COVID-19 patients needing
ventilator support for extended periods should be considered
especially at risk. Evidence of benefit from early mobilization
and physiotherapy comes from numerous randomized controlled
trials, systematic reviews, and recommendations (68, 69) and
is proven to be a safe and effective intervention. Early
mobilization (70), can be initiated during the mechanical
ventilation to counteract ICU-acquired weakness. However, an
agreed method of early mobilization in mechanically ventilated
patients is currently lacking, thus limiting reproducibility and
dissemination of shared protocols (71). While official guidelines
suggest the use of early mobilization protocols, they do not
recommend a specific one (72) and international practices
are heterogeneous (61). Unfortunately, there is also limited
awareness of the clinical benefits of early mobilization and
physiotherapy techniques and when used, disagreement on
the sustainable maximal level of activity in these critically-ill
patients. However, several factors including multidisciplinary
rounds, setting daily goals for patients, day-to-day availability of
dedicated physiotherapists, and an adequate nurse/patient ratio
are becoming significantly associated with the practice of early
mobilization in ICUs.
In our Swiss University Hospital, we adopt a pre-specified
procedure for early mobilization with clear entry and exit
points. In the ICU, mobilization of mechanically ventilated
patients is achieved using MOTOmed Letto R© (Reck & Co.
GmbH, Germany; an automatic system for leg movement
in a supine position, mimicking a bicycle, allowing passive,
active, or assisted mobilization) and Erigo R© (Hocoma AG,
Switzerland; a tilting table with an integrated leg movement
system, allowing progressive verticalization of the patient,
adjustable to the patient’s needs, and possibilities) as soon
as cardiovascular stability of the patient is attained. Many
animal and human studies suggest that intermittent exposure
to gravity throughout long periods of bed rest is sufficient
to prevent deconditioning (73) and improve outcome after
awakening from a coma (74). Verticalization is now integrated
into a neuro-sensorial approach in acute neuro-rehabilitation
and improves the results of tracheostomy weaning (75). In
addition, a multidisciplinary approach (physiotherapists, nurses,
physicians) allows a rapid and pertinent adaptation to the
different stages as it takes into account the great variability
in neurological deficits and the considerable intra-individual
requirements for patient management (75). A prospective
randomized study on patients with severe brain injuries showed
that mobilization with the lower-body ergometer MOTOmed R©,
was able to prevent polyneuromyopathy in critical-care illness
and to improve awareness in disorders of consciousness. Of
note, the use of the robot Erigo R© proved to be safer in
patients with subarachnoid hemorrhage as it has no effect on
the production of catecholamines (76). Futhermore, mobilization
has potentiation effect on arousal that may support cognitive
recovery as well (77).
Neurosensory Stimulation Approach
The restricted mobility, impaired communication, and social
isolation that COVID-19 patients experience in the ICU due to
mechanical ventilation may lead to severe sensory deprivation.
Environmental (i.e., sensory) deprivation is described as a
reduction in variety and intensity of sensory input (78) and can
slow down the recovery and development of CNS function (79).
Sensory deficits may have additional negative effects of majorly
stressing the body and so altering its physiological balance
(80). A rationale for treatment is to enrich the environment,
promoting the brain’s plasticity processes, thereby enabling
organizational, and functional modifications. Interventions use
multisensory-stimulation programs, which promote arousal,
and behavioral responsiveness from controlled exposure to
environmental or sensory-specific stimuli (81). Sensory stimuli
include visual, auditory, tactile, olfactory, gustatory, and
proprioceptive stimulation that can vary considerably in form,
intensity, and number of modalities but are typically variations
of multisensory stimulation, including the presentation of stimuli
that are structured, meaningful, multimodal, familiar, and with
emotional content. This maximizes the probability of cognitive
engagement (82). For instance, affective auditory stimulation can
be achieved by providing information about a time and place,
using the patient’s favorite music, playing the voice of a loved
one, talking to the patient about happy daily events in his/her
family or pleasant memories and enjoyable experiences; a tactile
and proprioceptive stimulation can be applied by massaging
the patient’s hands and legs and performing passive range-
of-motion activities several times; a visual stimulation can be
applied by using a picture of a family member, a family film,
or a picture with high positive valence; an olfactory stimulation
can be applied using aromatic stimuli including the patient’s
favorite aromas; a gustatory stimulation can be applied by placing
different kinds of food and flavors on the patient’s tongue with a
cotton bud.
In the clinic, multisensory stimulation is the core of
basal stimulation, a therapeutic concept developed by Andreas
Fröhlich (83) and subsequently transferred into nursing.
Basal stimulation aims to provide a structured and accessible
perceptual experience through stimulation of the body and
its movements. In addition, it aims to develop an individual,
non-verbal form of communication with people whose own
activity is limited by their lack of mobility and whose ability
to perceive and communicate is significantly impaired. Sensory
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stimulation is a non-invasive, safe, inexpensive, and simple-to-
apply rehabilitation approach, which has been widely studied
in patients with severe brain injuries experiencing alterations
in consciousness (84). Despite the lack of high-quality clinical
trials, the literature suggests that applying a sensory stimulation
protocol enhances the recovery process and improves outcomes
in severely brain-injured patients (84–86).
Cognitive Rehabilitation
Alongside respiratory physiotherapy and functional
rehabilitation, additional cognitive rehabilitation may be
required for COVID-19 patients who present neuropsychological
alterations in cognitive performance in the acute and immediate
post-acute phases. Formal rehabilitation pathways, comparable
to those used in stroke and traumatic brain injury patients,
do not yet exist for survivors of acute COVID-19 (87, 88).
However, as awareness of COVID-19-induced cognitive
impairments grows, rehabilitation strategies should also focus on
cognitive recovery.
Cognitive rehabilitation is a broad term referring to
therapeutic approaches that address the cognitive deficits caused
by lesions or illnesses affecting the brain’s optimal functionality.
Most methods use either a restorative or compensatory approach
(88). The restorative approach aims at rehabilitating cognitive
functions by reinforcing, strengthening, or re-establishing
previously learned patterns of behavior. It includes repeated
exercise of standardized cognitive tests of increasing difficulty
that target specific cognitive domains (e.g., selective attention,
memory for new information). In contrast, the compensatory
approach uses alternative strategies (e.g., internal residual
strengths or external compensatory mechanisms including
environmental structure and support) that compensate for
the decline in cognitive function. Several principles underpin
its process and effectiveness (89). Therapeutic interventions
have shown greater benefit when integrated as part of a
multidisciplinary rehabilitative approach (90) and tailored to
the individual needs with goals regularly reassessed (91).
Additionally, if interventions are of increasing intensity (92)
and begin as soon after injury as possible (89), they are more
likely to be successful. In patients with acquired cerebral lesions
including traumatic brain injury and stroke, successful cognitive
rehabilitation has previously been demonstrated. Systematic
reviews on evidence-based cognitive rehabilitation emphasize
the importance of functional, patient-centered outcomes. They
advise developing individualized and motivational interventions
documented by more subjective outcome measures (93).
As previously hypothesized, patients with severe, and critical
COVID-19 may present with disturbances primarily in executive
functions including severe akinesia (as seen in cognitive-
motor dissociation), as well as in attention and memory.
Moreover, attention and memory deficits may be exacerbated
following periods of delirium. This can lead to additional
disturbances in other complex cognitive functions, such as
interpersonal communication skills. Similar to patients with
severe brain injuries, the acute rehabilitative treatment of
COVID-19 patients should aim to improve attention and
stimulate the networks responsible for conscious perception and
environmental interaction. Promoting motivational stimulation
(94, 95) and increasing sensory input (84) may increase
adequate goal-oriented behaviors, enhance the recovery process,
and minimize the risk of functional disability (88). Post-
acute rehabilitation of COVID-19 patients should focus on
interventions that improve everyday functioning. They should
directly apply compensatory strategies to functional contexts
while considering appropriate infection-control measures. This
may necessitate the use of remote support services such as
tele-rehabilitation, virtual care platforms, and communication
devices (96).
Respiratory Support and Physiotherapy
Severely and critically ill patients suffer varying degrees of
dysfunction, especially respiratory insufficiency during the acute
and recovery stages. The goal of early rehabilitation intervention
is to reduce breathing difficulties, relieve symptoms, ease anxiety
and depression, and lower the incidence of complications.
Rehabilitation interventions in severely or critically ill
COVID-19 patients can only begin when the minimum
clinical stability has been achieved. Treatments should be
immediately withdrawn in cases of high fever, worsening
dyspnea, a respiratory rate > 30 breaths/minute, pulse oximetry
< 93% on oxygen therapy or requiring FiO2 > 50% during
non-invasive ventilation (NIV), positive end expiratory pressure
(PEEP)/continuous positive airway pressure (CPAP) >10 cm
H2O, respiratory distress, arterial hypertension, brady- or
tachycardia, intercurrent arrhythmias, shock, deep sedation,
or evidence of radiological lesion progression (>50%) within
24–48 h. Rehabilitation therapy in these cases mainly includes
position management, respiratory training, and mild physical
exercise. Frequent changes of posture, passive mobilization,
and/or neuromuscular electrical stimulation should be planned
especially in the unconscious patient (97). In addition, evaluation
of peripheral muscle strength trends [by the Medical Research
Council [MRC] scale and dynamometers] should be recorded
as soon as practicable. Airway clearance techniques are not
recommended in the acute phase. Indeed, the hypothetical
benefits do not outweigh the contamination risk for operators.
The risk/benefit ratio should be evaluated on a single-case
basis in patients with bronchiectasis or with evident bronchial
encumbrance using tools at a safe distance from the patient,
which can be maintained.
After discharge from intensive care or an intermediate care,
patients may present with disability and functional damage
(respiratory function, critical illness myopathy, and neuropathy),
reduced participation, and deterioration of quality of life, either
in the short- and long-term following discharge. Recovery
time is variable depending on the degree of normocapnic
respiratory failure and associated physical (asthenia, peripheral
muscle weakness) and emotional (anxiety, depression, sense
of abandonment, post-traumatic stress syndrome) dysfunction
(55). Comorbidities make longer the return to the former
condition. Evaluation of exercise capacity and oxygenation
response on effort (by the 6-min walk test) and at nighttime
should be planned as soon as possible. For patients bedridden
for extended periods, an assessment of balance function is
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especially recommended. Further suggestions include: evaluation
of peripheral muscle strength by the MRC scale, measurement of
joint range-of-motion (ROM), andmanual and isokinetic muscle
tests. Simple and repeatable treatment protocols for weaning
patients from oxygen therapy are indicated. Reconditioning
interventions are advised in weaned patients and those requiring
prolonged weaning from mechanical ventilation and oxygen use,
to improve the physical status and to rebalance the motor, and
cognitive consequences of prolonged immobilization (72, 98).
Exercise involving a gradual load increase is recommended to
regain normal function. Low intensity exercise (< 3.0 metabolic
equivalents), daily patient counseling, and education are urged.
Patients discharged home or to other facilities in the community
should receive instruction on physical activity plans. These
must be closely monitored regarding function, capacity, and
participation once the patient is no longer contagious.
Concerning tracheotomy weaning, our experience emphasizes
the importance of patient positioning (head in high flexion)
and regular tracheostomy care (cleaning the stoma, changing
the inner cannula, aspirations). We use the Facial Oral Tract
Therapy (FOTT R©) concept and patient positioning according
to the Bobath R© concept (99) as stimulation techniques that
we start immediately on patient admission. Deflation of the
cuff is performed during treatment sessions, as soon and
as often as possible, with the longest permissible duration,
depending on the patient’s tolerance. Cuff deflation, even in
patients with altered consciousness, avoids deafferentation of
the oropharyngeal region. The cuff is inflated during respiratory
physiotherapy when ventilation is required and humidification is
constantly provided. An appropriate stimulation (cuff deflation,
stimulation of upper airway respiration, swallowing, coughing,
and verbal communication) it’s helpful to avoid sensory
deafferentation. Physicians and physiotherapists must work
closely with the Ear Nose and Throat (ENT) specialists. The
timing of the first trans-cannulation depends on the type of
tracheostomy in question. Use of the open surgical approach
is recommended between the second and fifth days while
the percutaneous dilatational approach is favored after 10
days. A fenestrated outer cannula is inserted at this moment,
with the cuff deflated to allow air to flow over the vocal
folds when the orifice is plugged by a finger, speaking valve,
or stopper. The stimulation from airflow passing over the
vocal cords is essential for laryngeal re-afferentation. When
saliva-flow management seems to be safe and ventilation
treatment is no longer need, the tracheostomy tube can
be removed.
Several studies have confirmed that intervention by a
multidisciplinary team reduces weaning time (47, 99, 100).
Although several individualized, non-comparative, and non-
validated decannulation protocols exist, there is no universally
accepted protocol. Additionally, randomized clinical trails
are lacking on this critical issue. However, our group has
demonstrated the benefits of the interdisciplinary neurosensory
weaning program in a retrospective study. It showed a reduction
in weaning failure rate from 27 to 9%. Furthermore, the time
to decannulation after admission decreased from 19 to 12
days (101).
Early and intensive treatments conducted by a specialized
team reduce the complications associated with bed rest
therefore improving patient outcomes (102). Defining specific
guidelines for individual patient pathways will enable creating
treatment plans suitable for multiple settings (75). Ineffective
cough and secretion retention can play a significant role in
weaning failure. In this respect, evaluation of cough strength
by peak expiratory flow rate can predict extubation failure
and may reduce the length of ICU stay and as a result,
costs, morbidity, and mortality may also decrease. Cough
stimulation techniques, including lung volume recruitment or
manually and mechanically assisted cough are used to facilitate
extubation and prevent post-extubation respiratory failure.
However, the sub-standard quality of studies on this topic make
it difficult to draw conclusions regarding the effectiveness of the
techniques (103).
CONCLUSIONS
Although our understanding of COVID-19 is still incomplete, a
growing body of evidence indicates potential deleterious effects
on CNS and PNS function. This may lead to complex and
long-lasting physical, cognitive, and functional impairments.
Beginning rehabilitation in the acute stage of the disease is
required to combat this.
COVID-19 is associated with a cascade of negative concurrent
factors, including some unrelated to the disease per se, all
having a potentially heavy impact on disability and global
functioning. This additive effect with ability to induce multi-
organ dysfunction is peculiar to COVID-19 and differentiates
it from CNS, PNS, heart and lung diseases for example, which,
even when very severe, rarely display such a pleiotropic effect.
Patients with severe COVID-19 are likely therefore, to present
with a variety of serious sequelae associated with the viral illness,
including prolonged stay in the ICU, immobilization, mechanical
ventilation, tracheotomy, sedation, delirium, all aggravated by
preexisting comorbidities.
Given the high proportion of hospitalization in critical care
units, it is likely that a considerable number of survivors will
require rehabilitation due to these sequelae. Hence, rehabilitation
will be a key component in the continuum of patient-centered
care and rehabilitation professionals will have a critical role in
assisting patient recovery from COVID-19-associated disabling
effects. Indeed rehabilitation by a multidisciplinary team should
start as early as possible since prompt intervention has proven
efficient in counteracting the vicious circle of disease-related and
indirect ICU side-effects. Accordingly, individualized treatment
plans should be implemented.
Based on the experience of our acute interdisciplinary
neuro-rehabilitation team in managing severely brain-injured
patients, we would recommend applying an early and intensive
rehabilitation program for severe COVID-19 patients that
aims at maximizing patient function to achieve the highest
possible level of independence (Figure 2). Such programs
consist of a combination of approaches including early
mobilization, multimodal sensory, and cognitive stimulation,
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tracheotomy-weaning strategies, cardiovascular training and
monitoring and respiratory management. These have been
shown to improve functional outcomes and quality of life,
reduce the social and emotional burdens for the patient
and family, and reduce the length of hospitalization and
related costs.
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